Trump's Plan to Lower Drug Prices
Digest more
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels could result in 15% operating profit cuts in the industry.
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen next.
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, expand access, and save more lives, the company says. But by shifting patients to a version protected by newer patents,
Shares of Alphamab Oncology plunged 14.4% to HK$6.28, leading declines in Hong Kong-listed pharmaceutical stocks.Meanwhile, the U.S. and China said they have agreed to slash reciprocal tariffs, aiming to ease a trade war that has unsettled global markets.
Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on prescription drug imports.
Why It Matters: This move is expected to have the biggest impact on Medicare Part B drugs, which mainly constitute outpatient prescriptions and biologicals, the prices for which are directly ...
1d
President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits on what the government will pay
According to the timeline laid out in President Donald Trump’s May 12 executive order, prescription drug price reductions would not happen "almost immediately." The order specifies a 30-day period to develop pricing targets for drugmakers,
Feedback